Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick G Pilié

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|May 14, 2019
Durable complete response in renal cell carcinoma clinical trialsPatrick G Pilié, Eric Jonasch
Kidney Cancer (Clifton, Va.)|October 19, 2018
Systematic Review: Perioperative Systemic Therapy for Metastatic Renal Cell CarcinomaPatrick G Pilié, Eric Jonasch
Oncotarget|March 23, 2019
SET-ing the stage for PI3Kβ inhibitor sensitivity in clear cell renal cell carcinomaPatrick G Pilié, Eric Jonasch
JAMA Oncology|July 7, 2018
Broadening the View of Germline Mutations in Kidney CancerPatrick G Pilié, Kathleen A Cooney
Lancet (London, England)|March 1, 2026
Impact of adding hormone therapy to postoperative radiotherapy in prostate cancerAna M Aparicio, Patrick G Pilié
Future Oncology (London, England)|March 30, 2016
Key considerations in the treatment of von Hippel-Lindau diseasePatrick G Pilié, Eric Jonasch, Ian E McCutcheon
Molecular Cancer Therapeutics|December 6, 2017
Precision Medicine: Progress, Pitfalls, and PromisesPatrick G Pilié, Patricia M LoRusso, Timothy A Yap
Cancer Research|December 1, 2018
Development of PARP and Immune-Checkpoint Inhibitor CombinationsRoss A Stewart, Patrick G Pilié, Timothy A Yap
Nature Reviews. Clinical Oncology|October 26, 2018
State-of-the-art strategies for targeting the DNA damage response in cancerPatrick G Pilié, Chad Tang, Gordon B Mills, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
scEMB: Learning context representation of genes based on large-scale single-cell transcriptomicsKang-Lin Hsieh, Yan Chu, Xiaoyang Li, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|May 14, 2019
Durable complete response in renal cell carcinoma clinical trialsPatrick G Pilié, Eric Jonasch
Kidney Cancer (Clifton, Va.)|October 19, 2018
Systematic Review: Perioperative Systemic Therapy for Metastatic Renal Cell CarcinomaPatrick G Pilié, Eric Jonasch
Oncotarget|March 23, 2019
SET-ing the stage for PI3Kβ inhibitor sensitivity in clear cell renal cell carcinomaPatrick G Pilié, Eric Jonasch
JAMA Oncology|July 7, 2018
Broadening the View of Germline Mutations in Kidney CancerPatrick G Pilié, Kathleen A Cooney
Lancet (London, England)|March 1, 2026
Impact of adding hormone therapy to postoperative radiotherapy in prostate cancerAna M Aparicio, Patrick G Pilié
Future Oncology (London, England)|March 30, 2016
Key considerations in the treatment of von Hippel-Lindau diseasePatrick G Pilié, Eric Jonasch, Ian E McCutcheon
Molecular Cancer Therapeutics|December 6, 2017
Precision Medicine: Progress, Pitfalls, and PromisesPatrick G Pilié, Patricia M LoRusso, Timothy A Yap
Cancer Research|December 1, 2018
Development of PARP and Immune-Checkpoint Inhibitor CombinationsRoss A Stewart, Patrick G Pilié, Timothy A Yap
Nature Reviews. Clinical Oncology|October 26, 2018
State-of-the-art strategies for targeting the DNA damage response in cancerPatrick G Pilié, Chad Tang, Gordon B Mills, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
scEMB: Learning context representation of genes based on large-scale single-cell transcriptomicsKang-Lin Hsieh, Yan Chu, Xiaoyang Li, et al.
Pageof 3